Meta-methoxy-alpha-methyl-phenethyl-amino-diphenylmethyl ethers
    4.
    发明授权
    Meta-methoxy-alpha-methyl-phenethyl-amino-diphenylmethyl ethers 失效
    甲基 - 甲氧基 - 氨基 - 甲基 - 苯乙烯 - 氨基 - 二苯基甲基醚

    公开(公告)号:US3565955A

    公开(公告)日:1971-02-23

    申请号:US3565955D

    申请日:1967-10-23

    Applicant: HOECHST AG

    CPC classification number: B41M5/136

    Abstract: BASICALLY SUBSTITUTED DIPHENYL-METHYL ETHERS OF THE FORMULA

    1-((R-PHENYL)-CH(-PHENYLENE-R1)-O-CH2-CH2-N(-CH3)-

    CH(-CH3)-CH2-),3-(CH3-O-),R4-BENZENE

    IN WHICH R AND R1 ARE HYDROGEN, CHLORINE, BROMINE, HYDROXYL, ALKYL OF 1 TO 3 CARBON ATOMS, OR ALKOXY OF 1 TO 3 CARBON ATOMS, AND R4 IS HYDROGEN OR METHOXY HAVING BENEFICIAL PHYSIOLOGICAL ACTIVITY IN THE TREATMENT OF HEART AND CIRCULATORY DISEASES.

    10.
    发明专利
    未知

    公开(公告)号:DE1568567A1

    公开(公告)日:1970-03-19

    申请号:DE1568567

    申请日:1966-08-13

    Applicant: HOECHST AG

    Abstract: 1,193,657. Substituted phenylacetamides. FARBWERKE HOECHST A.G. 11 Aug., 1967 [13 Aug., 1966], No. 37048/67. Heading C2C. Novel substituted phenylacetamides of the formula in which R 1 , R 2 and R 3 each represent an identical or different, saturated or unsaturated aliphatic hydrocarbon radical containing up to 4 carbon atoms are prepared by one of the following methods (a) Hydrolysis of an appropriately substituted phenylacetonitrile. (b) Reaction of ammonia on a suitably substituted phenylacetic acid or derivative thereof. (c) Dehydration of an ammonium salt of an appropriately substituted phenylacetic acid. (d) Hydrogenolysis of a suitably substituted N-benzyl- or N,N-dibenzyl-phenylacetamide. (e)Alkylation or alkenylation of an appropriately substituted 3-hydroxy-phenylacetamide. 3 - Hydroxyphenyldiethylacetamide is made by treating 3 - methoxyphenyldiethylacetamide with hydrobromic acid. 3 - Methoxyphenyldipropylacetonitrile is obtained by treating 3-methoxybenzyl cyanide with propyl bromide in the presence of sodium amide. Similarly using sec. butyl bromide, 3 - methoxyphenyl - ethyl - sec. butyl - acetonitrile is obtained from 3 - methoxy - phenyl - ethyl - acetonitrile which is in turn, obtained from 3- methoxybenzyl cyanide and ethyl bromide. Therapeutic compositions, having sedative properties and suitable for oral or parenteral administration, contain the above novel compounds as the active ingredient and pharmaceutically acceptable carriers.

Patent Agency Ranking